Navigation Links
Hospira dévoile sa stratégie appareil mondiale
Date:5/1/2013

LAKE FOREST, Illinois, 2er mai 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), principal fournisseur mondial de médicaments injectables et de technologies de perfusion, a dévoilé aujourd'hui sa stratégie appareil mondiale. Cette initiative vise à rationaliser et moderniser la gamme d'appareils afin de répondre aux besoins des clients et positionner la société pour une innovation et une croissance future tout en soutenant les progrès continus de rectification des appareils, y compris les efforts d'amélioration de la qualité.

« Compte tenu de la priorité croissante accordée à l'amélioration de la sécurité et des résultats cliniques du patient, dans le domaine de la santé, nous pensons que notre activité appareil est un facteur stratégique majeur pour la croissance d'Hospira et nous sommes déterminés à conserver notre position de leader à travers nos investissements actuels et futurs », déclare Richard Davies , directeur commercial d'Hospira. « Grâce à un portefeuille rationalisé et modernisé, nous allons réduire la complexité et améliorer la performance et mieux nous positionner pour répondre aux attentes actuelles des clients et des agences réglementaires tout en développant les technologies de l'avenir. »

La nouvelle stratégie appareil d'Hospira est basée sur la revue récemment effectuée par la société et récemment terminée de ses plus de 575 000 pompes intraveineuses installées dans le monde entier. La société a présenté sa nouvelle stratégie à la Food and Drug Administration (FDA)
'/>"/>

SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Reports First-Quarter 2012 Results
3. Hospira to Present at Upcoming Investor Conferences
4. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
5. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
6. Hospira to Host Conference Call for Second-quarter 2012 Results
7. Hospira Expands Board of Directors With Election of Dennis M. Fenton
8. Hospira Reports Second-Quarter 2012 Results
9. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
10. Hospira Reports Third-Quarter 2012 Results
11. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ... (OFT) approval condition to the announced tender offer for all of ... As a result of the waiver, the transaction is no longer ... offer on January 24, 2014 following the currently scheduled expiration time, ...
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), ... human disease, announced today that Dr. Roy Fleischmann from ... presenting data from Lexicon,s LX2931 Phase 2 ... American College of Rheumatology on Wednesday, November 9, 2011 ...
... Nov. 8, 2011 Mesa Laboratories, Inc. (NASDAQ: ... declared a regular quarterly dividend of $.13 per share of ... dividend will be payable December 15, 2011, to shareholders of ... in 1984 Mesa Labs has maintained strong cash positions and ...
Cached Medicine Technology:LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference 2LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference 3
(Date:7/11/2014)... Ticket Down is a reliable source for cheap Luke ... to the summer concert schedule, it just isn’t complete without a ... the biggest names in country music and one of the biggest ... “That’s My Kind of Night” tour featuring Lee Brice and Cole ... the rest of the summer and into the fall includes the ...
(Date:7/11/2014)... 2014 Biostimulants are widely applied in ... and ornamentals. These also help turf and ornamentals in ... roots. Turf, ornamentals, and flowers appear healthy and strong ... has increased from the last few years. The most ... is Europe, with around 40% share in 2013, and ...
(Date:7/11/2014)... of its kind has found that organic foods ... their conventional counterparts, including more antioxidants and fewer, ... at an unprecedented 343 peer-reviewed publications comparing the ... plant-based foods, including fruits, vegetables, and grains. The ... differences between organic and non-organic foods. , ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap Luke ... Over the years Luke Bryan has been honored by almost every ... well at award shows, but each summer, he hits the road ... the genre and this summer is more of the same. When ... popularity and success that is currently entitled to Luke Bryan. The ...
(Date:7/11/2014)... The “Proteomics Market by Technology (Protein Microarray, ... Resonance, X-ray Crystallography) - Instruments, Reagents & Services ... the major market drivers, restraints, and opportunities in ... the World (RoW). , The proteomics market has ... mainly due to the increasing need of proteomic ...
Breaking Medicine News(10 mins):Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 2Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 4
... Health and Safety Products Company, Kidz-Med, Inc. takes special notice ... Kidz-Med, Inc. along with its parent company, American Scientific Resources, ... role models for all families. , , In 1994, ... Sunday of each July, as a national day of commemoration, ...
... exposure during pregnancy to miniscule levels of carbon monoxide damages ... The journal BMC (BioMed Central) Neuroscience published ... "We expected the placenta to protect fetuses from the ... Edmond, professor emeritus of biological chemistry at the David Geffen ...
... Evanston, Ill., June 25 Lenox Hill Heart and ... Inc. (Mentice) partnered to coordinate the 1st trans-septal specific ... the Mentice VIST(TM) endovascular simulator to enhance the training ... , , The two-day course included didactic presentations, ...
... Reduce Access to Care for Dying Americans , , ... the country sent a letter to President Barack Obama urging him ... 1, 2009. , , The cuts threaten to ... patients and their family caregivers receive from hospice providers each year. ...
... , Funding supports multiple commercial, emerging and pilot projects ... for Stem Cell & Regenerative Medicine (CSCRM), comprised of ... (CC), University Hospitals (UH), and Athersys, Inc. has received ... Research Commercialization Program. The funding will help support new ...
... to Millennium Research Group (MRG), the global authority ... procedure adoption will accelerate over the next five ... deep vein thrombosis (DVT). Although the ATTRACT (Acute ... trial, which will compare catheter-directed thrombolysis (CDT) to ...
Cached Medicine News:Health News:Parents' Day is Coming - Kidz-Med Celebrates the Role of Parents 2Health News:Tiny levels of carbon monoxide damage fetal brain 2Health News:Lenox Hill Heart and Vascular Institute of New York and Mentice, Inc. Announce the Successful Completion of Their 1st Trans-septal Cardiac Catheterization Training Course: A Comprehensive Hands-On Tutorial with Certification on June 12th and 13th 2009 in 2Health News:Lenox Hill Heart and Vascular Institute of New York and Mentice, Inc. Announce the Successful Completion of Their 1st Trans-septal Cardiac Catheterization Training Course: A Comprehensive Hands-On Tutorial with Certification on June 12th and 13th 2009 in 3Health News:Hospice Community Urges President Obama to Stop Funding Cuts 2Health News:Case Western Reserve University Receives $5M From Third Frontier Commission for the Center for Stem Cell & Regenerative Medicine 2Health News:Case Western Reserve University Receives $5M From Third Frontier Commission for the Center for Stem Cell & Regenerative Medicine 3Health News:Case Western Reserve University Receives $5M From Third Frontier Commission for the Center for Stem Cell & Regenerative Medicine 4Health News:Case Western Reserve University Receives $5M From Third Frontier Commission for the Center for Stem Cell & Regenerative Medicine 5Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 3
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
Maximum contact. Minimum wear. Outstanding results....
... tricompartmental total knee prosthesis stems from many ... design and manufacturing technologies have been used ... as well as a favorable pressure distribution ... keep wear to a minimum. The inherent ...
...
Medicine Products: